Injuries

·MeSH: Wounds and Injuries

Prevalence

28698.8 / 100K

Incidence

12639.0 / 100K/yr

24 drugs in development·19 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
baclofen	Impax Laboratories, LLC (IPXL)
baclofen	ANI PHARMACEUTICALS INC (ANIP)
ultramist	SANUWAVE Health Inc. (SNWV)

Phase 3(3)

Drug	Company
acellular tissue engineered vessel / human acellular vessel	Humacyte Inc. (HUMA)
neocart	Ocugen, Inc. (OCGN)
plx-pad	Pluri Inc. (PLUR)

Phase 2(3)

Drug	Company
Filler Product	UNITED THERAPEUTICS Corp (UTHR)
multistem	ATHERSYS, INC / NEW (ATHX)
ntx-001	GH Research PLC (GHRS)

Phase 1(1)

Drug	Company
ast-opc1	ASTERIAS BIOTHERAPEUTICS, INC. (AST)

Preclinical(4)

Unknown(1)

Drug	Company
Celularity Tendon Wrap (CTW)	Celularity Inc. (CELU)

Phase 1/Phase 2(1)

Drug	Company
nvg-291	NERVGEN PHARMA CORP. (NGEN)

Phase 4(8)

Drug	Company
Acetaminophen 325Mg Tab	Structure Therapeutics Inc. (GPCR)
Acetaminophen 325Mg Tab	Cidara Therapeutics, Inc. (CDTX)
Acetaminophen 325Mg Tab	Filana Therapeutics Inc. (FLNA)
Norco 5Mg-325Mg Tablet	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Norco 5Mg-325Mg Tablet	Filana Therapeutics Inc. (FLNA)
Norco 5Mg-325Mg Tablet	Structure Therapeutics Inc. (GPCR)
Norco 5Mg-325Mg Tablet	Cidara Therapeutics, Inc. (CDTX)
Norco 5Mg-325Mg Tablet	PROTHENA CORP PUBLIC LTD CO (PRTA)

BioSniper tracks 24 drugs in development for Injuries across 19 companies.

There are 1 clinical trial targeting Injuries tracked by BioSniper.

The estimated prevalence of Injuries is approximately 28698.8 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.